In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...

Tuberculosis (TB) remains one of the world's most serious public health threats, with approximately one-quarter of the global ...

Multidrug-resistant (MDR) tuberculosis is defined as disease caused by strains of Mycobacterium tuberculosis that are at least resistant to treatment with isoniazid and rifampicin; extensively ...

Tuberculosis is usually treated with a 6-month rifampin-based regimen. Whether a strategy involving shorter initial treatment may lead to similar outcomes is unclear. In this adaptive, open-label, ...

Tuberculosis (TB) remains a major global health problem, with over a million deaths annually. Effective TB vaccines and ...

AN ESTIMATED one in five tuberculosis (TB) cases in the WHO European Region are undiagnosed or unreported, according to a new ...